Massachusetts
The Massachusetts Board of Pharmacy issued the following orders:
- Policy 2023-07: Non-Sterile Compounding: Several modifications regarding the addition of flavoring agents were added.
- Policy 2023-09: Action Level Environmental Monitoring Results: Clarified that highly pathogenic microorganisms will be those determined by a qualified microbiology professional.
- Policy 2020-15: Scope of Practice: Statement that the pharmacist is responsible for the accuracy of the final dispensed prescription was added.
- Compounded Ketamine: Edits to this document include the FDA cautions regarding the use of all compounded ketamine products, not just nasal spray.
- Sterile Injectable Dispensing (Including Testosterone): Reviews how to interpret the proper days’ supply of injectable vials.
For more information, please contact NACDS’ Ben Pearlman at 617-515-2603.
Michigan
Medicaid issued a bulletin announcing prescription copay change for Healthy Michigan Plan enrollees.
Also in Michigan, The Department of Licensing and Regulatory Affairs (LARA) issued an email communication to pharmacies regarding the new Pharmacy Technician Administrative Rules that were effective on Oct. 2, 2023. They noted they are diligently working on updating relative information on their website to reflect the revision. Please send questions about the revised rules to BPLHELP@michigan.gov.
For more information, contact NACDS’ Jill McCormack at 717-592-8977.
Minnesota
The Secretary of State announced open positions on the Prescription Drug Affordability Board (PDAB) and the PDAB Advisory Council. Applications may be submitted on the Open Positions page. If you are interested in applying, please contact NACDS’ Jill McCormack to coordinate.
Also in Minnesota, the Department of Health (MDH) has opened registration to all manufacturers, wholesalers, pharmacies, and pharmacy benefit managers required to submit prescription drug price transparency reports. Beginning in 2024, prescription drug manufacturers, pharmacies, wholesalers, and pharmacy benefit managers will be required to report quarterly on drugs of substantial public interest identified by MDH. All reporting entities are required to register with MDH’s online reporting system beginning January 1, 2024. MDH’s guide to registering provides more detail on the process.
Upcoming Implementation Steps:
- January 1, 2024: registration requirement goes into effect
- By January 31, 2024: MDH releases the first list of drugs of substantial public interest for reporting
- Thirty (30) or more days after the drug list is posted, MDH will notify reporting entities of their reporting obligations; reporting entities have 60 days after the notification is sent to report
- Early 2024: MDH will release finalized reporting guidance
For more information, contact NACDS’ Jill McCormack at 717-592-8977.
Missouri
The Board of Pharmacy hosted a webinar providing new information on the Prescription Drug Monitor Program (PDMP).
For more information, contact NACDS’ Mary Staples at 817-442-1155.
Montana
The Board of Pharmacy and the Board of Veterinary Medicine posted the Joint Full Board Meeting Agenda for December 7. The meeting will be held by teleconference only; see agenda for details. Information is available on the Board meetings page.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
Nebraska
The Department of Health and Human Services issued Provider Bulletin 23-31: Hepatitis C Virus (HCV) Antiviral Treatment to notify Medicaid providers of upcoming changes to HCV antiviral treatment requirements.
Also in Nebraska, the Department of Health and Human Services issued Provider Bulletin 32-30: Claims for Reinstated Medicaid Members to inform Medicaid providers of members whose coverage has been reinstated due to recent federal guidance. Additional information on Medicaid member reimbursement is also available online, including copays for prescription drugs paid to pharmacies.
Finally in Nebraska, the Department of Health and Human Services posted the draft minutes from the November 14 Drug Utilization Review Board meeting. The next meeting will be held on January 9, 2024.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
Nevada
The next meeting of the Board of Pharmacy will be in Las Vegas on December 6 and 7.
For more information, contact NACDS’ Mary Staples at 817-442-1155.
New York
Effective November 29, the New York Department of Health issued updated guidance regarding dispensing of COVID-19 over-the-counter tests at the pharmacy.
NYRx, the New York State Medicaid Pharmacy Benefit Program, sent a release to pharmacy providers on December 6th. The program continues to field questions and concerns from residency program coordinators about pharmacies not able to submit claims to NYRx written by their interns and residents. NYRx asked the following shared regarding submission of claims:
For more information, please contact NACDS’ Ben Pearlman at 617-515-2603.
Ohio
The Board of Pharmacy has issued the following communications:
- Important Dates.pdf
- Quick Reference Guide – Pharmacy Technician Trainee Registration Requirements.pdf
Also in Ohio, the Senate passed SB 144 by a vote of 30-1. This is a priority bill for pharmacy that would permanently authorized pharmacists and both certified and registered technicians to administer all vaccines to patients aged five and older. Action in the House is expected in 2024.
For more information, contact NACDS’ Jill McCormack at 717-592-8977.
Oklahoma
The Bureau of Narcotics and Dangerous Drugs (OBN) alerted the Board of Pharmacy of the ongoing cyberattack regarding Ardent Health Services that is affecting multiple facilities in the state including Hillcrest Health System, Bailey Medical Center, and Utica Park Clinics, among others. The Board issued guidance for pharmacies that receive prescriptions for controlled substances from Ardent Health providers to continue filling the prescriptions received while continuing due diligence in confirming the prescription itself is valid and accurate, regardless of the manner or media received. This is a temporary solution to ensure prescribers can continue patient care until they can obtain OBN prescription pads.
For more information, contact NACDS’ Mary Staples at 817-442-1155.
Oregon
The Board of Pharmacy announced the December 13-15 Board meeting agenda and meeting materials are now available. Please note the consideration of rules for adoption related to vaccines pursuant to the enactment of HB 2486 and HB 2278 this year.
Also in Oregon, the Prescription Drug Affordability Board posted a draft agenda for the December 13 meeting. Board calendar and materials from past meetings are also available online.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
Tennessee
On December 5, Belmont University will host a free, live webinar providing a one-hour Board of Pharmacy update from 6:30-7:30 pm CT. All pharmacists and pharmacy technicians in Tennessee are welcome to register.
Also in Tennessee, TennCare recently released a notice regarding changes to the TennCare pharmacy program, specifically to the morphine milligram equivalent (MME), which will become effective January 1, 2024.
For more information, contact NACDS’ Leigh Knotts at 803-243-7207.
Texas
United Supermarkets’ pharmacist Tim Purser and his wife Charity who is standing next to Gov. Gregg Abbott (R), accompanied NACDS to a Lubbock fundraiser for the Chair of the House Calendars Committee, Dustin Burrows (R).
Also in Texas, Texas Comptroller Glenn Hegar (R) announced the Opioid Abatement Fund Council (OAFC) decisions to approve up to $25 million over the next year of opioid settlement trust funds to be allocated for each grant plan strategy – the distribute Naloxone, the promotion of substance abuse and prevention by raising awareness of students in grades kindergarten through 12th , as well as their parents and caregivers, and bolstering training, recruitment and retention, and certification assistance for the behavioral health workforce. The OAFC had previously approved rules for distribution of $166.7 million of the funds to more than 150 hospital districts over 18 years. Additionally, last March $47.1 million of the Opioid Abatement funds was distributed to political subdivisions.
Also in Texas, the Board of Pharmacy adopted and proposed several new rules at their November meeting.
Also in Texas, the PMP Advisory Committee meeting will be meeting virtually December 14th.
Finally in Texas, Attorney General Ken Paxton (R) is suing Pfizer for “misrepresenting COVID-19 vaccine efficacy and conspiring to censor public discourse, arguing that Pfizer’s claim that the COVID-19 vaccine was 95% effective against infection was “highly misleading.” The lawsuit also charges that Pfizer engaged in a conspiracy to silence dissent by coordinating with social media companies to remove “truth-tellers” from their platforms.
For more information, contact NACDS’ Mary Staples at 817-442-1155.
Washington
The Department of Health’s Pharmacy Quality Assurance Commission (PQAC) filed a rulemaking inquiry to consider possible amending language on prescription transfers requested by the patient.
Also in Washington, the Health Care Authority (HCA) published a new Medicaid program integrity training for providers which includes pharmacy, COVID-related issues and general program integrity overview and activities. The information provided in this educational intervention is not intended to be a comprehensive detailed account of all legal requirements relevant to compliance with Medicaid program integrity laws and regulations and satisfies the law requiring annual training in RCW 74.09.195.
Also in Washington, the HCA updated the Prescription Drug Program Billing Guide, effective for dates of service on and after December 1, 2023. Revisions include added vaccines that can be billed through the point-of-sale pharmacy system, updated pharmacy billing information for vaccines and vaccine administration, and updated professional dispensing fee allowances for pharmacies to align with recently filed emergency rules.
For more information, contact NACDS’ Mary Staples at 817-442-1155.
Alaska
The Board of Pharmacy is meeting on November 16. The agenda and public packet are available on the Board’s website.
For more information, contact NACDS’ Mary Staples at 817-442-1155.
Arkansas
Candidates interested in running for state and federal offices in 2024 filed for office on November 6 through 14, 2023. At the top of the ballot will be the Presidential race, then the four U.S. Congressional House of Representatives seats, plus eighteen members of the thirty-five member Arkansas Senate, all one hundred members of the Arkansas House of Representatives. The primary election date is March 5, 2024, followed by the runoff on April 2, 2024, and the general election on November 5, 2024.
For more information, contact NACDS’ Mary Staples at 817-442-1155.
California
The Department of Health Care Services (DHCS) posted the following alerts and weekly notices on the Medi-Cal Rx Web Portal.
- Medi-Cal Rx Weekly Wrap-up for November 3-9 (November 10)
- Reinstatement Spotlight (November 10)
- Enteral Nutrition Updates to the List of Contracted Enteral Nutrition Products, Effective November 1, 2023 (November 8)
- November Provider Payment Release Date Change (November 8)
- Reminder: Reinstatement of Brand Medically Necessary Prior Authorization Request Requirements for DAW (Dispense as Written) 1 Claims (November 8)
- Deactivation of Override Code "55555" for Select Drug/Products – Medi-Cal Rx Program Integrity Update (November 3)
- Medi-Cal Rx Weekly Wrap-up for October 27-November 2 (November 3)
- Reinstatement Spotlight (November 3)
Also in California, the DHCS (Department of Health Care Services) also posted the following:
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
Florida
Due to a delay in verifying the Medicaid weekly funding, provider payments will not be available until November 17. Please note that the “Payment Issue Date” on the remittance advice and all other generated information will remain the same. If you need assistance or have questions about provider payments, please contact the Provider Services Contact Center at 1-800-289-7799, option 7. This is a one-time delay with the regular weekly Thursday payment schedule. Due to the holiday falling on the regular weekly Thursday schedule, payment will be made on November 22.
For more information, contact NACDS’ Leigh Knotts at 803-243-7207.
Georgia
Gov. Brian P. Kemp (R) has extended the State of Emergency for Inflation, which suspended the state’s excise tax on motor and locomotive fuel. The executive order will remain in effect until 11:59 pm on November 29.
For more information, contact NACDS’ Leigh Knotts at 803-243-7207.
Indiana
The Family and Social Services Administration (FSSA) provided pharmacy updates approved by Drug Utilization Review Board in October.
For more information, contact NACDS’ Mary Staples at 817-442-1155.
Kansas
The Board of Pharmacy adopted a new guidance document regarding when a prescriber must request a waiver before non-electronically prescribing a controlled substance in schedule II-V that contains an opiate. While the Board’s guidance is primarily aimed at prescribers, pharmacists should be aware of their responsibilities when they receive a non-electronic prescription of a controlled substance in schedule II-V that contains an opiate.
For more information, contact NACDS’ Mary Staples at 817-442-1155.
Kentucky
NACDS reminds members that as of October 16, the MedImpact vaccine administration fee was raised to $27.49 for the first dose in a vaccine series and $9.80 for each subsequent dose in a series. Currently, pharmacies are permitted to administer all vaccines to patients 9 years of age and older (including adults) by protocol. Also notable, DMS (Department for Medicaid Services) no longer requires pharmacies to enroll in VFC (Vaccines for Children) to be reimbursed for children's vaccines if the patient meets the age requirements in statute.
Also in Kentucky, Medicaid issued Provider Notice #315 regarding September P&T PDL (Preferred Drug List) changes.
For more information, contact NACDS’ Jill McCormack at 717-592-8977.
Louisiana
November 18 is the date for runoff election for those statewide and state legislative races. Chain pharmacies are closely watching State Rep. Barbara Frieberg (R) race in Baton Rouge, as she was our champion that fought for the immunizations bill that died in the last two hours of the legislative session that would have made the federal PREP (Public Readiness and Emergency Preparedness) Act efficiencies permanent.
Also in Louisiana, if the Louisiana Legislature wants to prevent a district court from changing its congressional map, it has until January 15 to produce a new redistricting plan, the 5th Circuit Court of Appeals ruled on November 10.
Also in Louisiana, the Board of Pharmacy's quarterly meeting was on November 15 in Baton Rouge.
Also in Louisiana, Medicaid announced that by the end of the year there will be a new Naloxone Standing Order signed by Dr. Shantel Hebert-Magee, the state's new Medicaid Chief Medical Officer, once Dr. James Hussey retires. Pharmacies need to take note for 2024 billing purposes.
Finally in Louisiana, the Single Pharmacy Benefits Manager (PBM) for Managed Care Organizations (MCO) managed by Magellan, was finally implemented on October 28. Magellan Medicaid Administration Inc. is now processing Medicaid MCO (managed care organization) pharmacy claims for all six MCOs (Managed Care Organizations) (Aetna Better Health, AmeriHealth Caritas, Healthy Blue, Humana Healthy Horizons, Louisiana Healthcare Connections and UnitedHealthcare Community Plan). The Magellan Medicaid Administration portal is live with helpful information.
For more information, contact NACDS’ Mary Staples at 817-442-1155.
Massachusetts
On November 15, the Massachusetts State Senate unanimously passed, S 2520, “An Act relative to pharmaceutical access, costs and transparency.” The bill combined several previously pending bills that NACDS had been monitoring and advocating. S 2520 includes PBM (pharmacy benefit manager) registration and reporting in addition to other efforts towards drug cost containment by the manufacturers. The bill is now sent to the House where it is pending action. The Massachusetts legislative session will continue until July 31, 2024.
For more information, please contact NACDS’ Ben Pearlman at 617-515-2603.
Michigan
Medicaid issued proposed policy 2341 Documenting Beneficiary Consent Authorizing Automatic Refills of Prescribed Pharmacy Products for public comment.
For more information, contact NACDS’ Jill McCormack at 717-592-8977.